SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Keyur Patel, Nicholas A. Shackel, Current status of fibrosis markers, Current Opinion in Gastroenterology, 2014, 30, 3, 253

    CrossRef

  2. 2
    Petra Thulin, Gunnar Nordahl, Marcus Gry, Getnet Yimer, Eleni Aklillu, Eyasu Makonnen, Getachew Aderaye, Lars Lindquist, C. Mikael Mattsson, Björn Ekblom, Daniel J. Antoine, B. Kevin Park, Stig Linder, Alison H. Harrill, Paul B. Watkins, Björn Glinghammar, Ina Schuppe-Koistinen, Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts, Liver International, 2014, 34, 3
  3. 3
    Kenneth Cusi, Zhi Chang, Steve Harrison, Romina Lomonaco, Fernando Bril, Beverly Orsak, Carolina Ortiz-Lopez, Joan Hecht, Ariel E. Feldstein, Amy Webb, Christopher Louden, Martin Goros, Fermin Tio, Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease, Journal of Hepatology, 2014, 60, 1, 167

    CrossRef

  4. 4
    R. Anty, S. Patouraux, A. Tran, P. Gual, Obésité et maladie du foie gras non alcoolique, Obésité, 2014,

    CrossRef

  5. 5
    Heike Bantel, Katharina John, Klaus Schulze-Osthoff, Robust Detection of Liver Steatosis and Staging of NAFLD by an Improved ELISA for Serum Cytokeratin-18 Fragments, The American Journal of Gastroenterology, 2014, 109, 1, 140

    CrossRef

  6. 6
    Jing Chen, Yueyong Zhu, Qi Zheng, Jiaji Jiang, Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis, Hepatology Research, 2014, 44, 5
    D